VaramirStart free · no cardSign in
TARA as of Nov 2 · 04:26 ET
TARANasdaqBiological Products, (No Diagnostic Substances)

Protara Therapeutics, Inc. · Brief

Next report

7 days

Nov 9 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±22.3%
avg realized
±2.7%
Nov 12 '24±12.9%0.00%×0.00
Mar 5 '25±43.6%▲+8.04%×0.18
May 8 '25±17.9%▲+0.60%×0.03
Aug 11 '25±26.8%▼−0.96%×0.04
Q3 FY25±24.4%▲+5.59%×0.23
Q1 FY26±17.9%▼−0.70%×0.04
May 13 '26±13.2%▲+0.97%×0.07
Q2 FY26±21.5%▼−4.87%×0.23
quarterimplied−45%0+45%realized×
Q2 FY26±21.5%▼−4.87%×0.23
May '26±13.2%▲+0.97%×0.07
Q1 FY26±17.9%▼−0.70%×0.04
Q3 FY25±24.4%▲+5.59%×0.23
Aug '25±26.8%▼−0.96%×0.04
May '25±17.9%▲+0.60%×0.03
2 older reports
Mar '25±43.6%▲+8.04%×0.18
Nov '24±12.9%0.00%×0.00
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

119managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+2.71%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
6 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

TARA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±23.5% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.